The European clinical trials directive and its impact on critical care and emergency research

Current Opinion in Critical Care

Volumn 17, Issue 2, 2011, Pages 141-145

  Robinson, Katy ^a   Andrews, Peter J D ^b,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

clinical trial; emergency medicine; European Directive; informed consent; intensive care medicine; legislation; temporarily incapacitated patient

Indexed keywords

CRITICALLY ILL PATIENT; EMERGENCY CARE; EUROPE; EUROPEAN CLINICAL TRIALS DIRECTIVE; EUROPEAN UNION; FINANCIAL MANAGEMENT; GOOD CLINICAL PRACTICE; GOOD MANUFACTURING PRACTICE; GOVERNMENT REGULATION; HUMAN; INFORMED CONSENT; INSURANCE; INTENSIVE CARE; MEDICAL ETHICS; MEDICAL RESEARCH; MONITORING; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; REVIEW; RISK ASSESSMENT;

CLINICAL TRIALS AS TOPIC; CRITICAL CARE; EUROPE; GOVERNMENT REGULATION; HEALTH SERVICES RESEARCH; HUMANS;

EID: 79953093117     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e328342a6b0     Document Type: Review

References (44)

1. Hemminki A. Harmful impact of EU Clinical Trials Directive. Br Med J 2006;332:501-502. (Pubitemid 44364364)
2. Delawi D, Dhert WJA, Oner FC. Conducting a European multicentre trial: first experiences with the new European Clinical Trials Directive from an academic perspective. Eur Spine J 2008;17:1113-1115.
3. Hearn J, Sullivan R. The impact of the 'clinical trials'Directive on the cost and conduct of noncommercial cancertrials in the UK. Eur J Cancer 2007;43:8-13. (Pubitemid 46054481)
4. Impact on Clinical Research of European Legislation (ICREL) project final report. February 2009. A survey aimed at 'objectively measuring the impact of the clinical trials legislation on key stakeholder groups'5 years after its implementation. It gives a detailed and comprehensive account of the impact of the Directive on clinical trial activity; workload and costs through information from various stakeholders (including competent authorities, ethics committees, noncommercial sponsors and commercial sponsors), from different countries and from different areas of research.
5. European Parliament. Directive 2001/20/EC of the European Parliament and Council of 4th April 2001. Official J L 2001;121:34-44.
6. Law of 7 May 2004 concerning experiments on the human person: Loi relative aux Experimentations sur la Personne Humaine (LEH).
7. 154th Act of 1997 on health-care: 1997. évi CLIV. törvényazegészségügyrǒl.
8. Research Involving Human Subjects Act (WMO) 1998.
9. Health Research Act: Act 20-06-2008 No. 44.
10. Royal Decree 223/2004 of 6 February, on clinical trials involving medicinal products: Real Decreto 223/2004, de 6 de febrero, por el que se regulan los ensayos clínicos con medicamentos.
11. Public health law no. 2004-806: Loi 2004-806 du 09 aout 2004, relative à la politique de santé publique.
12. Act Concerning the Ethical Review of Research Involving Humans (SFS 2003:460;
13. updated in SFS 2008:192).
14. The European Communities (Clinical Trials on Medicinal Products for Human Use) Regulations 2004.
15. The Medical Research Act 488/1999 (amended by 295/2004).
16. Adults with Incapacity (Scotland) Act 2004.
17. The Mental Capacity Act 2005.
18. The Medicines Act (Arneimittelgesetz) of 1983, last amended in 2008 (BGBI. I Nr. 115/2008).
19. The German Drug Act (Arzneimittelgesetz; AMG).
20. Legislative decree no. 211 of 24 June 2003.
21. Groupe de Travail Coordination de l'Evaluation des Essais Cliniques (Working group for the evaluation of clinical trials). Recherche en situation d'urgence avec des personnes provisiorement ou durablemment incapables de discernement (Research in emergency situations and with people temporarily or permanently incapable of giving consent). May 2006. http://www.swissethics.ch/ index.php?id=51&L=1.
22. The EFGCP Report on the Procedure for Ethical Review of Protocols for Clinical Research Projects in the European Union. April 2010. Written by a subgroup of the European Forum for Good Clinical Practice, this document details the ethical review process for each member state and is regularly updated.
23. The Act on a Biomedical Research Ethics Committee System and the Processing of Biomedical Research Projects no. 402 of 28 May 2003 (amended in Act No. 272 1 of April 2006).
24. Singer EA, Mullner, M. Implications of the EU directive on clinical trials for emergency medicine: Many trials in emergency medicine will not be possible. BMJ 2002;324:1169-1170. (Pubitemid 34547913)
25. Sterz F, Singer E, Bottiger B, et al. A serious threat to evidence based resuscitation within the European Union. Resuscitation 2002;53:237-238. (Pubitemid 34607721)
26. Lemaire F, Bion J, Blanco J, et al. The European Directive on Clinical Research: present status of implementation in EU member states'legislations with regard to the incompetent patient. Intensive Care Med 2005;31:476-479.
27. Liddell K, Chamberlain D, Menon DK, et al. The European Clinical Trials Directive revisited: the VISEAR recommendations. Resuscitation 2006;69:9-14.
28. Woltz M, Druml C, Leitner D, Singer EA. Protocols in expedited review: tackling the workload of ethics committees. Intensive Care Med 2009;35:613-615.
29. Williams N. Breast Cancer Research and the European Union Clinical Trials Directive. Breast Cancer Res 2004;6:145-147. (Pubitemid 39136479)
30. The European Science Foundation. Forward Look: Investigator-driven clinical trials. March 2009. Following a series of workshops, a series of recommendations were formulated to strengthen investigator-driven clinical trials within Europe.
31. Singer EA, Druml C. Collateral damage or apocalypse now for European academic research. Intensive Care Med 2005;31:271. (Pubitemid 40362277)
32. Druml C. Informed consent of incapable (ICU) patients in Europe: existing laws and the EU Directive. Curr Opin Crit Care 2004;10:570-573. (Pubitemid 39620211)
33. Liddel K, Bion J, Chamberlain D, et al. Medical research involving incapacitated adults: implications of the EU Clinical Trials Directive 2001/20/EC. Med Law Rev 2006;14:367-417. (Pubitemid 44659307)
34. Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM). Cited: Impact on Clinical Research of European Legislation (ICREL) project final report. February 2009.
35. Bulletin: Clinical trials of drugs in Italy. National Monitoring Centre for Clinical Research with Medicines. http://www.agenziafarmaco.it/en/content/ nationalmonitoring-centre-clinical-trials. [Accessed 2 December 2010]
36. Berendt L, Hakansson C, Bach KF, et al. Effect of the European Clinical Trials Directive on academic drug trials in Denmark: retrospective study of applications to the Danish Medicines Agency 1993-2006. Br Med J 2008;336:33-35.
37. Hoey R. The EU Clinical Trials Directive: 3 years on. Lancet 2007;369:1777-1778.
38. Welzing L, Harnischmacher U, Weyersberg A, Roth B. Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population: a field report. Eur J Paediatr 2007;166:1169-1176. (Pubitemid 47476632)
39. European Cancer Organisation backs proposals to revise EU Clinical Trials Directive. Expert Rev Anticancer Ther 2010;10:301-303.
40. Mason E. European Commission considers revisions to clinical trials directive. J Natl Cancer Inst 2010;102:292-294.
41. Medical Research Council Clinical Trials tool-kit. http://www.ct-toolkit. ac.uk/.
42. The European Commission. Assessment of the Functioning of the 'Clinical Trials Directive'2001/20/EC Public Consultation Paper. Brussels; 09 October 2009. http://ec.europa.eu/health/files/clinicaltrials/docs/2009-10-09-public- consultation-paper.pdf. After announcing an assessment of the Clinical Trials Directive, this public consultation paper was launched by the European Commission, with a view to considering opinions on how to improve the Clinical Trials Directive and making appropriate legislative proposals. It details many of the publicized problems with the Directives and asks for opinions on the impact of these and various solutions.
43. The European Commission. Assessment of the Functioning of the 'Clinical Trials Directive'2001/20/EC Summary of Responses to the Public Consultation Paper. Brussels; 30 03 March 2010. http://ec.europa.eu/health/files/ clinicaltrials/2010-03-30-summary-responses.pdf. This gives a summary of responses to the above public consultation paper.
44. The European Commission. Legislative proposal on a Regulation/Directive amending the Clinical Trials Directive 2001/20/EC. 23 March 2010. http://ec.europa.eu/governance/impact/planned-ia/docs/47-sanco-clinical-trials- directive-en.pdf.